As stroma occupies a major part in the tumor volume, FAP-targeted radiotracers may increase the target sensitivity and image contrast of the disease area compared to the targeting of glucose metabolic pathway in cancer cells solely due to their lack of brain uptake in contrast to [18F]FDG. This evidence concerns the gene FAP and neoplasm.